New York, New York–(Newsfile Corp. – December 31, 2024) – Why: Rosen Law Firm, a global investor rights law firm, sells stocks that have purchased call options or sold put options. We are cautioning purchasers of common stock, including: ASML Holding NV (NASDAQ: AS:) January 24, 2024 through October 15, 2024 (inclusive) (the “Class Period”), with a key lead plaintiff deadline of January 13, 2025. .
This means that if you purchased ASML common stock and/or purchased a call option and/or sold a put option during the Class Period, you will be compensated without paying any out-of-pocket fees or costs through a contingency fee arrangement. You may be entitled to receive.
What to do next: To join the ASML class action, go to https://rosenlegal.com/submit-form/?case_id=31159 or call Phillip Kim. For more information, please contact us at 866-767-3653 or email case@rosenlegal.com. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 13, 2025. Lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
Why Rosen Law: We encourage investors to select talented attorneys with a track record of success in leadership roles. Companies issuing notices often do not have comparable experience, resources, or meaningful peer evaluations. Many of these firms do not actually litigate securities class actions; they are simply intermediaries who refer clients or work with law firms that actually litigate cases. Be wise when choosing a lawyer. The Rosen Law Firm represents investors throughout the world, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest securities class action settlement at the time against a Chinese company. Rosen Law Firm was ranked #1 for securities class action settlements in 2017 by ISS Securities Class Action (WA:) Services. The firm has been ranked in the top four every year since 2013 and has recovered hundreds of millions of dollars in litigation. investors. In 2019 alone, the company secured over $438 million from investors. In 2020, founding partner Lawrence Rosen was named a Titan of Plaintiffs’ Lawyers by Law360. Many of our attorneys have been recognized by Lawdragon and Super Lawyers.
Case Details: According to the lawsuit, during the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) suppliers like ASML in the semiconductor industry; The issuers facing are tougher than the defendants have shown investors. (2) the pace of sales recovery in the semiconductor industry was much slower than Defendants had publicly acknowledged; (3) Defendants falsely created the impression that they had reliable information regarding customer demand and expected growth, while at the same time exposing themselves to risks from macroeconomic and industry fluctuations and to semiconductors, including the products sold by ASML. He also downplayed stricter regulations restricting technology exports. (4) As a result, Defendants’ statements regarding ASML’s business, operations, and prospects lacked a reasonable basis; When the true details entered the market, the lawsuit claims investors suffered damages.
To join the ASML class action, go to https://rosenlegal.com/submit-form/?case_id=31159 or call Phillip Kim. Toll-free 866-767-3653 or email case@rosenlegal.com for information on the class action.
There are no certified classes. Until a class is certified, you are not represented by counsel unless you retain one. You can choose the lawyer of your choice. You can also remain absent and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent on whether he or she serves as lead plaintiff.
For the latest information, please follow us on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, Twitter: https://twitter.com/rosen_firm, or Facebook (NASDAQ:): https:/ follow me. /www.facebook.com/rosenlawfirm/.
Lawyer advertisement. Previous results do not guarantee similar results.
—————————–
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/235715.
